by Emily Yoffe at The Free Press: Eithan Haim, 34, is at the beginning of his career as a surgeon. He and his wife are expecting their first child in the fall. And now he is facing a four-count federal felony indictment for blowing the whistle on Texas Children’s Hospital, where he worked while a resident.
At TCH, he discovered the hospital was secretly continuing gender transition treatments on minors—including hormonal intervention on patients as young as 11 years old—after publicly declaring, in March of 2022, it would no longer provide such services.
The hospital unwillingly backed away from the treatments under pressure from the Texas governor and attorney general. But Haim found not only were the treatments continuing—the program appeared to be expanding. He recorded several online presentations by medical staff encouraging the transition of children—one social worker described how she deliberately did not make note of such treatment in the medical charts of patients to avoid leaving a paper trail. Haim told me, “They were talking publicly about how they were concealing what they were doing. You can’t take care of your patient without trust. For me as a doctor, to not do something about this was unconscionable.”
Haim, like a growing number of medical professionals around the world, had grave doubts about the safety and efficacy of the explosively growing business of youth gender transition medicine. When he looked into it, he found that children distressed about their biological sex often had multiple mental health challenges—conditions that were being ignored in the rush to put vulnerable young people on hormones, and even to perform surgical interventions. These treatments are profoundly life-altering, with a high risk of rendering a young person sterile. In the last few years, a growing number of countries have investigated these treatments for young people, found the evidence wanting, and have effectively banned interventions such as puberty blockers—drugs that prevent children from entering puberty.
More here.
